EZH2 and posterior cortical atrophy: The histone methyltransferase enhancer of zeste homolog 2 (EZH2) inhibits the transcription of downstream target genes mainly by methylation of H3K27, and it has been shown to be significantly overexpressed in NEPC clinical samples compared to PCa samples[18].